Top

Published in:

01-10-2021 | Endarterectomy | Heart Failure (HJ Eisen, Section Editor)

Chronic Thromboembolic Pulmonary Hypertension: the Bedside

Authors: Yuri Matusov, Inderjit Singh, Yen-Rei Yu, Hyung J. Chun, Bradley A. Maron, Victor F. Tapson, Michael I. Lewis, Sudarshan Rajagopal

Published in: Current Cardiology Reports | Issue 10/2021

Abstract

Purpose of Review

Chronic thromboembolic pulmonary hypertension (CTEPH), included in group 4 PH, is an uncommon complication of acute pulmonary embolism (PE), in which emboli in the pulmonary vasculature do not resolve but rather form into an organized scar-like obstruction which can result in right ventricular (RV) failure. Here we provide an overview of current diagnosis and management of CTEPH.

Recent Findings

CTEPH management is complex with treatments that range from surgery, percutaneous interventions, to medical therapies. Current CTEPH medical therapies have largely been repurposed from pulmonary arterial hypertension (PAH).

Summary

The diagnosis of CTEPH can be challenging, requiring a multimodality approach to differentiate from disease mimics. While these treatments improve symptoms, they may not reverse the underlying pathology of CTEPH.

Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: Evidence of overdiagnosis. Arch Intern Med. 2011;171(9):831–7.PubMedPubMedCentralCrossRef

Fedullo P, Kerr KM, Kim NH, Auger WR. Chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2011;183(12):1605–13.PubMedCrossRef

Piazza G, Goldhaber SZ. Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2011;364(4):351–60.PubMedCrossRef

Sista AK, Miller LE, Kahn SR, Kline JA. Persistent right ventricular dysfunction, functional capacity limitation, exercise intolerance, and quality of life impairment following pulmonary embolism: Systematic review with meta-analysis. Vasc Med. 2017;22(1):37–43.PubMedCrossRef

Klok FA, van Kralingen KW, van Dijk AP, Heyning FH, Vliegen HW, Huisman MV. Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. Haematologica. 2010;95(6):970–5.PubMedPubMedCentralCrossRef

Guerin L, Couturaud F, Parent F, Revel MP, Gillaizeau F, Planquette B, et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thromb Haemost. 2014;112(3):598–605.PubMedCrossRef

Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350(22):2257–64.PubMedCrossRef

Klok FA, Dzikowska-Diduch O, Kostrubiec M, Vliegen HW, Pruszczyk P, Hasenfuss G, et al. Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. J Thromb Haemost. 2016;14(1):121–8.PubMedCrossRef

Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, Delcroix M, Pruszczyk P, Mairuhu AT, et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J. 2017;49(2).

10.

Konstantinides SV, Vicaut E, Danays T, Becattini C, Bertoletti L, Beyer-Westendorf J, et al. Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism. J Am Coll Cardiol. 2017;69(12):1536–44.PubMedCrossRef

11.

Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L. Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysis. Circulation. 1999;99(10):1325–30.PubMedCrossRef

12.

Klok FA, van der Hulle T, den Exter PL, Lankeit M, Huisman MV, Konstantinides S. The post-PE syndrome: a new concept for chronic complications of pulmonary embolism. Blood Rev. 2014;28(6):221–6.PubMedCrossRef

13.

Kim NH, Delcroix M, Jais X, Madani MM, Matsubara H, Mayer E, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019;53(1).

14.

Madani MM, Auger WR, Pretorius V, Sakakibara N, Kerr KM, Kim NH, et al. Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. Annals of Thoracic Surgery. 2012;94(1):97–103.CrossRef

15.

Klok FA, Couturaud F, Delcroix M, Humbert M. Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Eur Respir J. 2020;55(6).

16.

Coquoz N, Weilenmann D, Stolz D, Popov V, Azzola A, Fellrath JM, et al. Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism. Eur Respir J. 2018;51(4):1702505.PubMedCrossRef

17.

Bonderman D, Turecek PL, Jakowitsch J, Weltermann A, Adlbrecht C, Schneider B, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2003;90(3):372–6.PubMedCrossRef

18.

Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 2000;343(7):457–62.PubMedCrossRef

19.

Wolf M, Boyer-Neumann C, Parent F, Eschwege V, Jaillet H, Meyer D, et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J. 2000;15(2):395–9.PubMedCrossRef

20.

Auger WR, Permpikul P, Moser KM. Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary-hypertension - a preliminary-report. American Journal of Medicine. 1995;99(4):392–6.CrossRef

21.

Newnham M, South K, Bleda M, Auger WR, Barbera JA, Bogaard H, et al. The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019;53(3).

22.

Sompradeekul S, Fedullo P, Le D, editors. Congenital and acquired thrombophilias in patients with chronic thromboembolic pulmonary hypertension. Am J Resp Crit Care; 1999: Amer Lung Assoc 1740 Broadway, New York, NY 10019 USA.

23.

Bonderman D, Wilkens H, Wakounig S, Schafers HJ, Jansa P, Lindner J, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009;33(2):325–31.PubMedCrossRef

24.

Becattini C, Agnelli G, Pesavento R, Silingardi M, Poggio R, Taliani MR, et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest. 2006;130(1):172–5.PubMedCrossRef

25.

de Perrot M, Fadel E, McRae K, Tan K, Slinger P, Paul N, et al. Evaluation of persistent pulmonary hypertension after acute pulmonary embolism. Chest. 2007;132(3):780–5.PubMedCrossRef

26.

Lang I, Kerr K. Risk factors for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006;3(7):568–70.PubMedCrossRef

27.

Berghaus TM, Barac M, von Scheidt W, Schwaiblmair M. Echocardiographic evaluation for pulmonary hypertension after recurrent pulmonary embolism. Thromb Res. 2011;128(6):e144–7.PubMedCrossRef

28.

Delcroix M, Kerr K, Fedullo P. Chronic thromboembolic pulmonary hypertension. epidemiology and risk factors. Ann Am Thorac Soc. 2016;13 Suppl 3(Suppl 3):S201–6.PubMedCrossRef

29.

Jais X, Ioos V, Jardim C, Sitbon O, Parent F, Hamid A, et al. Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax. 2005;60(12):1031–4.PubMedPubMedCentralCrossRef

30.

Wilkens H, Konstantinides S, Lang IM, Bunck AC, Gerges M, Gerhardt F, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018;272S:69–78.PubMedCrossRef

31.

Lang IM, Simonneau G, Pepke-Zaba JW, Mayer E, Ambroz D, Blanco I, et al. Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study. Thromb Haemost. 2013;110(1):83–91.PubMed

32.

Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D92–9.PubMedCrossRef

33.

Swan D, Hitchen S, Klok FA, Thachil J. The problem of under-diagnosis and over-diagnosis of pulmonary embolism. Thromb Res. 2019;177:122–9.PubMedCrossRef

34.

Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011;124(18):1973–81.PubMedCrossRef

35.

Auger W, Moser K. Pulmonary flow murmurs - A distinctive physical sign found in chronic pulmonary thromboembolic disease. Slack Inc 6900 Grove Rd, Thorofare, NJ 08086: Clinical Research; 1989.

36.

Fedullo PF, Auger WR. Clinical features and evaluation of chronic thromboembolic pulmonary hypertension. Medical Management of the Thoracic Surgery Patient: Saunders/Elsevier. 2010:477–82.

37.

Madani M, Jamieson SW. Chronic thromboembolic pulmonary hypertension and pulmonary thromboendarterectomy. Medical management of the thoracic surgery patient: Saunders/Elsevier. 2010:483–90.

38.

Woodruff W 3rd, Hoeck BE, Chitwood W Jr, Lyerly H, Sabiston D Jr, Chen J. Radiographic findings in pulmonary hypertension from unresolved embolism. Am J Roentgenol. 1985;144(4):681–6.CrossRef

39.

Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119.PubMedCrossRef

40.

Tunariu N, Gibbs SJR, Win Z, Gin-Sing W, Graham A, Gishen P, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med. 2007;48(5):680–4.PubMedCrossRef

41.

Moradi F, Morris TA, Hoh CK. Perfusion scintigraphy in diagnosis and management of thromboembolic pulmonary hypertension. Radiographics. 2019;39(1):169–85.PubMedCrossRef

42.

Ryan KL, Fedullo PF, Davis GB, Vasquez TE, Moser KM. Perfusion scan findings understate the severity of angiographic and hemodynamic compromise in chronic thromboembolic pulmonary hypertension. Chest. 1988;93(6):1180–5.PubMedCrossRef

43.

Narechania S, Renapurkar R, Heresi GA. Mimickers of chronic thromboembolic pulmonary hypertension on imaging tests: a review. Pulm Circ. 2020;10(1):2045894019882620.PubMedPubMedCentralCrossRef

44.

Gopalan D, Delcroix M, Held M. Diagnosis of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143):160108.PubMedCrossRef

45.

Ley S, Ley-Zaporozhan J, Pitton MB, Schneider J, Wirth GM, Mayer E, et al. Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol. 2012;22(3):607–16.PubMedCrossRef

46.

Reichelt A, Hoeper MM, Galanski M, Keberle M. Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography. Eur J Radiol. 2009;71(1):49–54.PubMedCrossRef

47.

Sugimura K, Fukumoto Y, Satoh K, Nochioka K, Miura Y, Aoki T, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2012;76(2):485–8.PubMedCrossRef

48.

Hasegawa I, Boiselle PM, Hatabu H. Bronchial artery dilatation on MDCT scans of patients with acute pulmonary embolism: comparison with chronic or recurrent pulmonary embolism. AJR Am J Roentgenol. 2004;182(1):67–72.PubMedCrossRef

49.

King MA, Ysrael M, Bergin CJ. Chronic thromboembolic pulmonary hypertension: CT findings. AJR Am J Roentgenol. 1998;170(4):955–60.PubMedCrossRef

50.

Giannouli E, Maycher B. Imaging techniques in chronic thromboembolic pulmonary hypertension. Curr Opin Pulm Med. 2013;19(5):562–74.PubMedCrossRef

51.

Pena E, Dennie C. Acute and chronic pulmonary embolism: an in-depth review for radiologists through the use of frequently asked questions. Seminars in Ultrasound, CT and MRI: Elsevier; 2012.

52.

Pitton MB, Duber C, Mayer E, Thelen M. Hemodynamic effects of nonionic contrast bolus injection and oxygen inhalation during pulmonary angiography in patients with chronic major-vessel thromboembolic pulmonary hypertension. Circulation. 1996;94(10):2485–91.PubMedCrossRef

53.

Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology. 1992;182(2):393–8.PubMedCrossRef

54.

Ghio S, Raineri C, Scelsi L, Recusani F, D'Armini AM, Piovella F, et al. Usefulness and limits of transthoracic echocardiography in the evaluation of patients with primary and chronic thromboembolic pulmonary hypertension. J Am Soc Echocardiogr. 2002;15(11):1374–80.PubMedCrossRef

55.

Jenkins D, Mayer E, Screaton N, Madani M. State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management. Eur Respir Rev. 2012;21(123):32–9.PubMedCrossRef

56.

Coulden R. State-of-the-art imaging techniques in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006;3(7):577–83.PubMedCrossRef

57.

Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1).

58.

Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J. 2009;34(4):888–94.PubMedCrossRef

59.

Guth S, Wiedenroth CB, Rieth A, Richter MJ, Gruenig E, Ghofrani HA, et al. Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease. Eur Respir J. 2018;52(3).

60.

Held M, Grun M, Holl R, Hubner G, Kaiser R, Karl S, et al. Cardiopulmonary exercise testing to detect chronic thromboembolic pulmonary hypertension in patients with normal echocardiography. Respiration. 2014;87(5):379–87.PubMedCrossRef

61.

Pandey AK, Lee NS, Marsal J, Knowlton KU, McDivit AM, Blanchard DG, et al. Evaluation of routine coronary angiography before pulmonary thromboendarterectomy. Ann Thorac Surg. 2021;111(5):1703–9.PubMedCrossRef

62.

van Kan C, van der Plas MN, Reesink HJ, van Steenwijk RP, Kloek JJ, Tepaske R, et al. Hemodynamic and ventilatory responses during exercise in chronic thromboembolic disease. J Thorac Cardiovasc Surg. 2016;152(3):763–71.PubMedCrossRef

63.

Held M, Kolb P, Grun M, Jany B, Hubner G, Grgic A, et al. Functional characterization of patients with chronic thromboembolic disease. Respiration. 2016;91(6):503–9.PubMedCrossRef

64.

Taboada D, Pepke-Zaba J, Jenkins DP, Berman M, Treacy CM, Cannon JE, et al. Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Respir J. 2014;44(6):1635–45.PubMedCrossRef

65.

Yin K, Zhang Z, Luo R, Ji Y, Zheng D, Lin Y, et al. Clinical features and surgical outcomes of pulmonary artery sarcoma. J Thorac Cardiovasc Surg. 2018;155(3):1109–15 e1.PubMedCrossRef

66.

Wyler von Ballmoos MC, Chan EY, Reardon MJ. Imaging and surgical treatment of primary pulmonary artery sarcoma. Int J Cardiovasc Imaging. 2019;35(8):1429–33.PubMedCrossRef

67.

Tandon R, Baughman RP, Stanley J, Khan AA. The link between chronic thromboembolic pulmonary hypertension and sarcoidosis: association or visual masquerade? Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(4):352–5.PubMedPubMedCentral

68.

Limsukon A, Fuller C, Lewis MI. Mediastinitis, fibrosing mediastinitis, and mediastinal hemorrhage. Medical Management of the Thoracic Surgery Patient: Saunders/Elsevier. 2010:405–14.

69.

McNeeley MF, Chung JH, Bhalla S, Godwin JD. Imaging of granulomatous fibrosing mediastinitis. AJR Am J Roentgenol. 2012;199(2):319–27.PubMedCrossRef

70.

Dion J, Terrier B, Jais X, Mehdaoui A, Sattler C, Amar D, et al. Atypical vasculitis mimicking chronic thromboembolic pulmonary hypertension. Am J Med. 2015;128(10):e47–9.PubMedCrossRef

71.

Zhu FP, Luo S, Wang ZJ, Jin ZY, Zhang LJ, Lu GM. Takayasu arteritis: imaging spectrum at multidetector CT angiography. Br J Radiol. 2012;85(1020):E1282–E92.PubMedPubMedCentralCrossRef

72.

Galie N, Kim NH. Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006;3(7):571–6.PubMedCrossRef

73.

Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest. 1982;81(2):151–8.PubMedCrossRef

74.

Jenkins D, Madani M, Fadel E, D'Armini AM, Mayer E. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143):160111.PubMedCrossRef

75.

Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation. 2006;113(16):2011–20.PubMedCrossRef

76.

• Bunclark K, Newnham M, Chiu YD, Ruggiero A, Villar SS, Cannon JE, et al. A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension. J Thromb Haemost. 2020;18(1):114–22. Retrospective study that showed that warfarin was associated with a lower risk of VTE than DOACs in CTEPH patients after PTE. Prospective randomized studies are required to address this question.PubMedCrossRef

77.

Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D'Armini AM, Snijder R, et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. Circulation. 2016;133(9):859–71.PubMedCrossRef

78.

Mahmud E, Madani MM, Kim NH, Poch D, Ang L, Behnamfar O, et al. Chronic thromboembolic pulmonary hypertension: evolving therapeutic approaches for operable and inoperable disease. J Am Coll Cardiol. 2018;71(21):2468–86.PubMedCrossRef

79.

Madani M, Mayer E, Fadel E, Jenkins DP. Pulmonary endarterectomy. patient selection, technical challenges, and outcomes. Ann Am Thorac Soc. 2016;13 Suppl 3:S240–7.PubMedCrossRef

80.

Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Resp Crit Care. 1999;160(2):523–8.CrossRef

81.

Thistlethwaite PA, Kaneko K, Madani MM, Jamieson SW. Technique and outcomes of pulmonary endarterectomy surgery. Ann Thorac Cardiovasc Surg. 2008;14(5):274–82.PubMed

82.

D'Armini AM, Morsolini M, Mattiucci G, Grazioli V, Pin M, Valentini A, et al. Pulmonary endarterectomy for distal chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2014;148(3):1005-11–2 e1-2 discussion 11-2.CrossRef

83.

Farasat S, Papamatheakis DG, Poch DS, Higgins J, Pretorius VG, Madani MM, et al. Atrial arrhythmias after pulmonary thromboendarterectomy. J Card Surg. 2019;34(5):312–7.PubMedCrossRef

84.

Havranek S, Fingrova Z, Ambroz D, Jansa P, Kuchar J, Dusik M, et al. Atrial fibrillation and atrial tachycardia in patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy. Eur Heart J Suppl. 2020;22(Suppl F):F30–F7.PubMedPubMedCentralCrossRef

85.

Jenkins DP, Madani M, Mayer E, Kerr K, Kim N, Klepetko W, et al. Surgical treatment of chronic thromboembolic pulmonary hypertension. Eur Respir J. 2013;41(3):735–42.PubMedCrossRef

86.

Moser KM, Metersky ML, Auger WR, Fedullo PF. Resolution of vascular steal after pulmonary thromboendarterectomy. Chest. 1993;104(5):1441–4.PubMedCrossRef

87.

Lee KC, Cho YL, Lee SY. Reperfusion pulmonary edema after pulmonary endarterectomy. Acta Anaesthesiol Sin. 2001;39(2):97–101.PubMed

88.

Thistlethwaite PA, Madani MM, Kemp AD, Hartley M, Auger WR, Jamieson SW. Venovenous extracorporeal life support after pulmonary endarterectomy: indications, techniques, and outcomes. Ann Thorac Surg. 2006;82(6):2139–45.PubMedCrossRef

89.

Berman M, Tsui S, Vuylsteke A, Snell A, Colah S, Latimer R, et al. Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. Ann Thorac Surg. 2008;86(4):1261–7.PubMedCrossRef

90.

Mayer E, Jenkins D, Lindner J, D'Armini A, Kloek J, Meyns B, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141(3):702–10.PubMedCrossRef

91.

Kramm T, Eberle B, Guth S, Mayer E. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardiothorac Surg. 2005;28(6):882–8.PubMedCrossRef

92.

Riedel B. The pathophysiology and management of perioperative pulmonary hypertension with specific emphasis on the period following cardiac surgery. Int Anesthesiol Clin. 1999;37(2):55–79.PubMedCrossRef

93.

Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008;177(10):1122–7.PubMedCrossRef

94.

Cannon JE, Su L, Kiely DG, Page K, Toshner M, Swietlik E, et al. Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom National Cohort. Circulation. 2016;133(18):1761–71.PubMedPubMedCentralCrossRef

95.

D'Armini AM, Zanotti G, Ghio S, Magrini G, Pozzi M, Scelsi L, et al. Reverse right ventricular remodeling after pulmonary endarterectomy. J Thorac Cardiovasc Surg. 2007;133(1):162–8.PubMedCrossRef

96.

Quadery SR, Swift AJ, Billings CG, Thompson AAR, Elliot CA, Hurdman J, et al. The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2018;52(3):52:1800589.PubMedCrossRef

97.

Lang IM, Dorfmuller P, Vonk NA. The pathobiology of chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc. 2016;13(Suppl 3):S215–21.PubMedCrossRef

98.

Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001;103(1):10–3.PubMedCrossRef

99.

Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5(6):748–55.PubMedCrossRef

100.

Kataoka M, Inami T, Hayashida K, Shimura N, Ishiguro H, Abe T, et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5(6):756–62.PubMedCrossRef

101.

Ogo T. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. Curr Opin Pulm Med. 2015;21(5):425–31.PubMedCrossRef

102.

Nagayoshi S, Fujii S, Nakajima T, Muto M. Intravenous ultrasound-guided balloon pulmonary angioplasty in the treatment of totally occluded chronic thromboembolic pulmonary hypertension. EuroIntervention. 2018;14(2):234–5.PubMedCrossRef

103.

Tatebe S, Fukumoto Y, Sugimura K, Miura Y, Nochioka K, Aoki T, et al. Optical coherence tomography is superior to intravascular ultrasound for diagnosis of distal-type chronic thromboembolic pulmonary hypertension. Circulation Journal. 2013;77(4):1081–3.PubMedCrossRef

104.

Ikeda N. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Cardiovasc Interv Ther. 2020;35(2):130–41.PubMedCrossRef

105.

Kawakami T, Ogawa A, Miyaji K, Mizoguchi H, Shimokawahara H, Naito T, et al. Novel angiographic classification of each vascular lesion in chronic thromboembolic pulmonary hypertension based on selective angiogram and results of balloon pulmonary angioplasty. Circ Cardiovasc Interv. 2016;9(10):e003318.PubMedCrossRef

106.

Hoole SP, Coghlan JG, Cannon JE, Taboada D, Toshner M, Sheares K, et al. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience. Open Heart. 2020;7(1):e001144.PubMedPubMedCentralCrossRef

107.

Brenot P, Jais X, Taniguchi Y, Garcia Alonso C, Humbert M, Fadel E, et al. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the initial experience at Paris-Sud University. D26 with friends like these: inside the spectrum of PE and CTEPH. Am Thorac Soc. 2018:A7788-A.

108.

Jin Q, Zhao ZH, Luo Q, Zhao Q, Yan L, Zhang Y, et al. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: State of the art. World J Clin Cases. 2020;8(13):2679–702.PubMedPubMedCentralCrossRef

109.

Ejiri K, Ogawa A, Fujii S, Ito H, Matsubara H. Vascular injury is a major cause of lung injury after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2018;11(12):e005884.PubMedCrossRef

110.

Ogawa A, Satoh T, Fukuda T, Sugimura K, Fukumoto Y, Emoto N, et al. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: results of a multicenter registry. Circ Cardiovasc Qual Outcomes. 2017;10(11):e004029.PubMedCrossRef

111.

Brenot P, Jais X, Taniguchi Y, Garcia Alonso C, Gerardin B, Mussot S, et al. French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019;53(5):1802095.PubMedPubMedCentralCrossRef

112.

Zoppellaro G, Badawy MR, Squizzato A, Denas G, Tarantini G, Pengo V. Balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension- a systematic review and meta-analysis. Circ J. 2019;83(8):1660–7.PubMedCrossRef

113.

Tanabe N, Kawakami T, Satoh T, Matsubara H, Nakanishi N, Ogino H, et al. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: A systematic review. Respir Investig. 2018;56(4):332–41.PubMedCrossRef

114.

Andreassen AK, Ragnarsson A, Gude E, Geiran O, Andersen R. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart. 2013;99(19):1415–20.PubMedCrossRef

115.

Darocha S, Banaszkiewicz M, Pietrasik A, Siennicka A, Piorunek M, Grochowska E, et al. Changes in estimated glomerular filtration after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. Cardiorenal Med. 2020;10(1):22–31.PubMedCrossRef

116.

Kriechbaum SD, Wiedenroth CB, Wolter JS, Hutz R, Haas M, Breithecker A, et al. N-terminal pro-B-type natriuretic peptide for monitoring after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2018;37(5):639–46.PubMedCrossRef

117.

Castro MA, Piloto B, Fernandes CJCD, Jardim C, Salibe W, Oleas FG, et al. Use of medical therapies before pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension patients with severe hemodynamic impairment. Plos One. 2020;15(5):e0233063.PubMedPubMedCentralCrossRef

118.

Ghofrani HA, D'Armini AM, Grimminger F, Hoeper MM, Jansa P, Kim NH, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369(4):319–29.PubMedCrossRef

119.

Simonneau G, D'Armini AM, Ghofrani HA, Grimminger F, Hoeper MM, Jansa P, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). Eur Respir J. 2015;45(5):1293–302.PubMedCrossRef

120.

Marra AM, Halank M, Benjamin N, Bossone E, Cittadini A, Eichstaedt CA, et al. Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study). Respir Res. 2018;19(1):258.PubMedPubMedCentralCrossRef

121.

Jais X, D'Armini AM, Jansa P, Torbicki A, Delcroix M, Ghofrani HA, et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008;52(25):2127–34.PubMedCrossRef

122.

Becattini C, Manina G, Busti C, Gennarini S, Agnelli G. Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. Thromb Res. 2010;126(1):e51–6.PubMedCrossRef

123.

Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jais X, et al. Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study. Lancet Respir Med. 2017;5(10):785–94.PubMedCrossRef

124.

Escribano-Subias P, Bendjenana H, Curtis PS, Lang I, Vonk NA. Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Pulm Circ. 2019;9(2):2045894019846433.PubMedPubMedCentralCrossRef

125.

Suntharalingam J, Treacy CM, Doughty NJ, Goldsmith K, Soon E, Toshner MR, et al. Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest. 2008;134(2):229–36.PubMedCrossRef

126.

• Sadushi-Kolici R, Jansa P, Kopec G, Torbicki A, Skoro-Sajer N, Campean IA, et al. Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial. Lancet Respir Med. 2019;7(3):239–48. Randomized clinical trial that demonstrated a significant increase in six-minute walk distance with treatment with subcutaneous treprostinil in nonoperable CTEPH.PubMedCrossRef

127.

Cabrol S, Souza R, Jais X, Fadel E, Ali RH, Humbert M, et al. Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2007;26(4):357–62.PubMedCrossRef

128.

Skoro-Sajer N, Bonderman D, Wiesbauer F, Harja E, Jakowitsch J, Klepetko W, et al. Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. J Thromb Haemost. 2007;5(3):483–9.PubMedCrossRef

129.

Olschewski H, Simonneau G, Galie N, Higenbottam T, Naeije R, Rubin LJ, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002;347(5):322–9.PubMedCrossRef

130.

Gabrielly M, Bourlier D, Taniguchi Y, Jevnikar M, Sekine A, Boucly A, et al. Initial dual oral combination therapy in inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Eur Respiratory Soc; 2018.CrossRef

131.

Kalra R, Duval S, Thenappan T, Raveendran G, Pritzker M, Prisco SZ, et al. Comparison of balloon pulmonary angioplasty and pulmonary vasodilators for inoperable chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis. Sci Rep. 2020;10(1):8870.PubMedPubMedCentralCrossRef

132.

Phan K, Jo HE, Xu J, Lau EM. Medical therapy versus balloon angioplasty for CTEPH: a systematic review and meta-analysis. Heart Lung Circ. 2018;27(1):89–98.PubMedCrossRef

133.

Wiedenroth CB, Ghofrani HA, Adameit MSD, Breithecker A, Haas M, Kriechbaum S, et al. Sequential treatment with riociguat and balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension. Pulm Circ. 2018;8(3):2045894018783996.PubMedPubMedCentralCrossRef

134.

Aoki T, Sugimura K, Terui Y, Tatebe S, Fukui S, Miura M, et al. Beneficial effects of riociguat on hemodynamic responses to exercise in CTEPH patients after balloon pulmonary angioplasty - A randomized controlled study. Int J Cardiol Heart Vasc. 2020;29:100579.PubMedPubMedCentral

Title: Chronic Thromboembolic Pulmonary Hypertension: the Bedside
Authors: Yuri Matusov
Inderjit Singh
Yen-Rei Yu
Hyung J. Chun
Bradley A. Maron
Victor F. Tapson
Michael I. Lewis
Sudarshan Rajagopal
Publication date: 01-10-2021
Publisher: Springer US
Keywords: Endarterectomy
Pulmonary Hypertension
Pulmonary Hypertension
Pulmonary Hypertension
Pulmonary Hypertension
Riociguat
Published in: Current Cardiology Reports / Issue 10/2021
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-021-01573-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Chronic Thromboembolic Pulmonary Hypertension: the Bedside

Abstract

Purpose of Review

Recent Findings

Summary

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 10/2021

Mitral Valve Annuloplasty Failure and Percutaneous Treatment Options

Familial Hypercholesterolemia: Global Burden and Approaches

Diagnosis and Management of Failed Surgical Tricuspid Valve Annuloplasty

Tricuspid Annuloplasty: Transcatheter Approaches

Vericiguat for Heart Failure with Reduced Ejection Fraction

Chronic Thromboembolic Pulmonary Hypertension: the Bench